Health-care companies ticked down amid skepticism about the deal market.
Novo Nordisk agreed to buy smaller rival Cardior Pharmaceuticals for up to $1.11 billion as the Wegovy maker seeks to develop products for cardiovascular disease and other areas outside of its core diabetes and weight-loss market.
Shares of Syra Health fell after the company recorded a wider loss on lower revenue in 2023. Medical-device maker Masimo may opt for a joint venture as it looks to split off its consumer business.
Medical-device maker Masimo may opt for a joint venture as it looks to split off its consumer business.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-25-24 1712ET
